Podcasts about chadi nabhan

What role do environmental toxins play in chronic disease, and how can we foster hope and resilience in cancer care? In this episode of Health Coach Talk, Dr. Sandi is joined by Dr. Chadi Nabhan, a distinguished oncologist, author, and advocate, to explore these critical questions. Together, they discuss his groundbreaking work linking glyphosate to cancer, his experiences during the Monsanto litigation trials, and his commitment to empowering patients and caregivers with knowledge and support. Show notes: https://functionalmedicinecoaching.org/podcast/chadi-nabhan-113/

A cancer diagnosis can change our lives and the lives of our loved ones in an instant. It leaves us seeking answers to myriad questions and searching for hope. In The Cancer Journey, Dr. Chadi Nabhan demystifies this complex disease and offers a compassionate guide to understanding your diagnosis and treatment options. With decades of experience treating oncology patients, Dr. Nabhan answers your essential questions about cancer, including how it develops, how it is diagnosed, how it is treated, and how to prevent it from returning. He provides suggestions for how readers can prepare for their first visit to a cancer specialist, what questions to ask the health care team, and insider tips for getting second opinions and clinical trials. This comprehensive guide covers screening, survivorship, the art of communication, complementary and integrative medicines, and the future of cancer care. For those who may be at risk or are newly diagnosed, for family members and friends seeking guidance to help their loved ones, and for non-specialist providers seeking to educate their patients, The Cancer Journey is your one-stop-shop for all the information you need.

Dr. Chadi Nabhan's dedication to oncology is deeply rooted in the human connection with his patients. With more than 20 years of experience, he joins Dorothy Gibbons to emphasize the importance of open communication and knowledge between patient and doctor. His journey highlights that trust and clear communication are fundamental to navigating the cancer journey. Key Questions Answered 1. What are the financial challenges related to waiving hospital fees for cancer patients? 2. How do social work, patient foundations, and philanthropy aid cancer patients? 3. Why is there a shortage of hospital and professional support compared to physicians willing to help patients? 4. Is cancer curable, and does it vary by type? 5. How do survival rates of cancer patients today compare to those 30 years ago? 6. Why is it important for cancer patients to seek second opinions? 7. How can patients manage their financial responsibilities related to cancer treatment? 8. What resources are available for uninsured cancer patients? 9. How should patients handle feelings of loss of control and guilt during cancer diagnosis and treatment? Timestamped Overview 00:00 Chief Medical Officer, podcaster, author, healthcare advocate. 03:04 Access to information often lacks clarity, accuracy. 09:39 Cancer diagnosis often leads to feeling powerless. 10:29 Dialogue and collaboration aid understanding and problem-solving. 14:35 Human connection is key in patient care. 19:21 They must know you're on their side. 20:18 Inner strength and support provide crucial guidance. 24:10 Seek multiple opinions for serious health issues. 28:25 Connect uninsured patients to charity care assistance. 31:10 Better cancer cures emerging with advanced understanding.See omnystudio.com/listener for privacy information.

Chadi Nabhan, author of The Cancer Journey, joins us to discuss how parents can talk to their teenagers about cancer, understand the common misconceptions, and best support teens when their peers or family members face a cancer diagnosis.If you've enjoyed Talking to Teens, we'd love if you could leave us a five-star rating, and if you have time, a review! Full Show NotesCancer is a challenging topic for families to discuss, especially when teenagers are involved. The fear, confusion, and misinformation surrounding cancer can make these conversations even more daunting. At some point, your teen might encounter a peer, teacher, or friend's family dealing with a cancer journey, and knowing how to communicate effectively about this sensitive subject is crucial. Parents often grapple with questions: how much should we tell our teens? How do we prepare our teenagers to engage with peers facing cancer in their families?To shed light on these difficult yet essential conversations, we're joined by Dr. Chadi Nabhan, a hematologist and medical oncologist, experienced in both patient care and cancer education. As the author of The Cancer Journey and host of the Healthcare Unfiltered podcast, Chadi discusses his approach to making complex medical topics accessible to a broad audience. His career focus on simplifying cancer information makes him the perfect guest for untangling this potentially overwhelming subject.In this episode, we delve into common misconceptions about cancer, such as the belief that cancer is primarily hereditary, and how these misunderstandings can impact conversations with teens. Chadi explains that while genes can play a role, many cancers develop without a family history, leaving individuals puzzled by their diagnoses. We explore the idea of cancer as a broad collection of diseases, each with unique characteristics and treatment paths. This distinction is vital when discussing potential impacts and prognoses with teens who may face generalizations about cancer prognosis.Communicating Effectively and RespectfullyDr. Nabhan shares insights on preparing teenagers to have compassionate conversations when a peer or their family members are facing cancer. He emphasizes the importance of not dismissing the severity of a cancer diagnosis, while also being respectful of personal boundaries regarding how much information others are willing to share. Teenagers should be encouraged to ask respectful questions and offer support without pressure, perhaps by simply being present or asking, “How can I help?”Furthermore, Chadi offers advice for parents going through their own cancer journey. He stresses the importance of timing and transparency in sharing a diagnosis with teens, noting when it might be best to wait before fully disclosing details, to gather complete information first. Parents can involve teens in medical appointments or calls to doctors, fostering involvement and understanding and providing a foundation for open communication.Empowering Teens with Knowledge and CompassionEducating teens about preventable cancers linked to viruses, like HPV, and the importance of vaccines as preventive measures are also highlighted in the discussion. Understanding these factors can empower teens with the knowledge to make informed health decisions and support their friends thoughtfully.By providing teens with the facts, helping them decode medical jargon, and encouraging empathy, parents can foster more meaningful and less fear-driven interactions surrounding cancer.Further Exploration in the Episode...Beyond the topics mentioned, the episode also covers:The role of targeted therapies and research advancements.How teens can cope with anxiety when they hear about cancer diagnoses in the news or through friends.Effective strategies for families to maintain open communication channels about tough topics.Don't miss this insightful episode, and remember to subscribe to Talking to Teens for more expert advice on navigating the teenage years.Follow us on Social Media! We're @talkingtoteens on Instagram and TikTok

On this episode of "The HemOnc Pulse," Saad Usmani, MD, of the Memorial Sloan Kettering Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss notable presentations on multiple myeloma from the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

Hearing the words, you have cancer, is a major fear for most people. A cancer diagnosis is shocking and scary – it can change your life and the lives of your loved ones in an instant. With so many questions and with a frightening road ahead, it's often difficult to know what to do. Dr. Chadi Nabhan has decades of experience treating oncology patients.  He discusses this complex disease and offers a compassionate guide to understanding a cancer diagnosis and treatment options. Dr. Nabhan is a board-certified hematologist and a medical oncologist who has authored or co-authored over 300 peer-reviewed manuscripts and abstracts. He is the creator and host of the weekly Healthcare Unfiltered podcast, and author of the book, The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention.   Follow CYACYL: Website: www.cyacyl.com Digital: www.cyacyl.com/digital Upcoming shows: www.cyacyl.com/shows Facebook: www.facebook.com/changeyourattitudechangeyourlife Music: www.purple-planet.com

On this episode of "The HemOnc Pulse," Chadi Nabhan, MD, MBA, FACP, is joined by Sangeetha Venugopal, MD, of the Sylvester Comprehensive Cancer Center at the University of Miami, to highlight data on myelodysplastic syndromes (MDS) presented at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

My guest is a medical oncologist and hematologist who is the author of the new book, “The Cancer Journey”. We discuss how, in this book, he simplifies the science, controversies, and complexity of cancer for patients and their loved ones. We discuss the importance of second opinions, modern cancer treatments, and much more.  

On this episode of "The HemOnc Pulse," Naval Daver, MD, of the MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss news on acute myeloid leukemia coming out of the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

In this insightful episode, we sit down with Dr. Chadi Nabhan, a renowned medical oncologist and hematologist, to discuss his latest book, The Cancer Journey. Dr. Nabhan's book aims to simplify complex cancer information, providing patients and families with an accessible guide through the often confusing and overwhelming landscape of cancer care. He covers key areas such as understanding a cancer diagnosis, the various treatment options available, and the pivotal role clinical trials can play in advancing care. Dr. Naban also stresses the importance of open communication between patients and oncologists, the need for trustworthy information in a sea of misleading content, and the value of considering integrative therapies as part of a comprehensive treatment approach. His mission is to empower patients to take an active role in their care, fostering a supportive and trusting relationship with their healthcare team.Key Takeaways:Trust your oncologist and healthcare team, and don't hesitate to ask questions about treatments and clinical trials.Use reliable resources, like The Cancer Journey, to cut through the noise and get clear, actionable information.Have open discussions with your doctor about integrative therapies to create a holistic treatment plan.Building a comfortable, communicative relationship with your healthcare provider is essential to navigating the cancer journey.----Learn more about what Dr. Chad Nabhan is up to:https://chadinabhan.com/----Grab my book A Better Way to Treat Cancer: A Comprehensive Guide to Understanding, Preventing and Most Effectively Treating Our Biggest Health Threat - https://www.amazon.com/dp/B0CM1KKD9X?ref_=pe_3052080_397514860 ----Integrative Cancer Solutions was created to instill hope and empowerment. Other people have been where you are right now and have already done the research for you. Listen to their stories and journeys and apply what they learned to achieve similar outcomes as they have, cancer remission and an even more fullness of life than before the diagnosis. Guests will discuss what therapies, supplements, and practitioners they relied on to beat cancer. Once diagnosed, time is of the essence. This podcast will dramatically reduce your learning curve as you search for your own solution to cancer. To learn more about the cutting-edge integrative cancer therapies Dr. Karlfeldt offer at his center, please visit www.TheKarlfeldtCenter.com

On this episode of "The HemOnc Pulse," Mazyar Shadman, MD, MPH, of the Fred Hutchinson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to highlight some of the notable presentations on chronic lymphocytic leukemia coming out of the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

Send us a textDr. Chadi Nabhan discusses his book THE CANCER JOURNEY: Understanding Diagnosis, Treatment, Recovery, and Prevention.Chadi Nabhan, MD, MBA, FACP, is a board-certified hematologist and a medical oncologist who practiced hematology and oncology for years. He has authored or co-authored over 300 peer-reviewed manuscripts and abstracts. He is the author of Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice and is the creator and host of the weekly Healthcare Unfiltered podcast.

On this episode of "The HemOnc Pulse," Prithviraj Bose, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss some of the important data on myeloproliferative neoplasms that were presented at the Society of Hematologic Oncology 2024 Annual Meeting in Houston, Texas.

In part two of this episode, Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center; Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; and Alan Skarbnik, MD, of Novant Health, continue to explore the role of measurable residual disease (MRD) in the treatment of patients with chronic lymphocytic leukemia (CLL). “The HemOnc Pulse” was live for in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in various hematologic malignancies. 

On “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, met with Afaf Osman, MD, an Assistant Professor at the University of Utah Huntsman Cancer Center, to discuss how high-risk myelodysplastic syndromes (MDS) are distinct from lower-risk classifications and how to approach treatment.

On “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, spoke with Rami Komrokji, MD, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida, about the state of myelodysplastic syndromes (MDS) care. Moffitt Cancer Center is home to a large MDS database, with clinical information on nearly 6,000 patients, a trove of real-world MDS data.

Show notes and links: https://www.chrisbeatcancer.com/dr-chadi-nabhan-expert-witness-against-monsanto-in-the-roundup-cancer-trials/

“The HemOnc Pulse” was live for the first time in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in a range of hematologic malignancies. As part of the program, Michael Bishop MD, of the University of Chicago, and Aaron Goodman, MD, of the University of California, San Diego, were joined by Rafael Fonseca, MD, of the Mayo Clinic, to hold a panel on bispecific therapies and explore unanswered questions related to them.

“The HemOnc Pulse” was live for the first time in Chicago, Illinois, on May 3-4 and featured host Chadi Nabhan, MD, MBA, FACP, moderating panels of academic and clinical experts who delved into unanswered questions in various hematologic malignancies. This episode explores questions in chronic lymphocytic leukemia (CLL) with Mazyar Shadman, MD, MPH, of Fred Hutchinson Cancer Center; Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center; and Alan Skarbnik, MD, of Novant Health.

On this ENCORE episode of YBYG Mike fights the good fight with Monsanto Trial Expert Witness Dr. Chadi Nabhan!  Plus in the Question of the week; Fleabane and its misbegotten misgivings!!  Plus your fabulous phone calls!!!

Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).

“The HemOnc Pulse” goes on the road to Chicago May 3-4 with host Chadi Nabhan, MD, MBA, FACP, for the first live meeting. This podcast episode features a panel discussion on unanswered questions in chimeric antigen receptor (CAR) T-cell therapy with Caron Jacobson, MD, MMSc, Medical Director of the Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute; Michael Bishop, MD, FACP, FASCO, Director of the Hematopoietic Stem Cell Transplantation Program at the University of Chicago; Joseph Mikhael, MD, MEd, FRCPC, FACP, a Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Research Institute, an affiliate of the City of Hope Cancer Center; and Alan Skarbnik, MD, Director of the Lymphoma and Chronic Lymphocytic Leukemia Program and Director of Experimental Therapeutics, Malignant Hematology at Novant Health.

"The HemOnc Pulse" goes on the road to Chicago with host Chadi Nabhan, MD, MBA, FACP. This podcast episode features a panel discussion on unanswered questions in acute myeloid leukemia (AML) with Naval Daver, MD, an Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center; Sanam Loghavi, MD, of the MD Anderson Cancer Center; Rami Komrokji, MD, the Vice-Chair of the Malignant Hematology Department at Moffitt Cancer Center in Tampa, Florida; and Mikkael Sekeres, MD, MS, a Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center at University of Miami Health. 

Toxic Exposure: The Monsanto Roundup Trials, and the Search for Justice," reveals the dark side of the world's most widely used herbicide. Jessica Aldridge interviewed Dr. Chadi Nabhan in 2023, who offered his expert insights on the link between glyphosate and cancer, the landmark legal battles against Monsanto, and the ongoing struggle for environmental justice. Tune in for a compelling narrative that exposes the failures of regulatory agencies and the courage of individuals standing up to agrochemical giants. Monsanto is now owned by Bayer, one of the largest agrochemical companies in the world. These companies and the EPA downplayed the health dangers of Roundup and the active ingredient glyphosate even after Monsanto lost numerous court cases (owing billions in judgements) and settled out of court for more than $11 Billion for more than 100K patients. In this interview we discuss the history of Roundup, the dangers of glyphosate, the trial stories and verdicts, and what the everyday person can do to fight for justice against this agricultural behemoth. Dr. Chadi Nabhan is an expert in lymphoid malignancies and treating and diagnosing cancers. He is author of Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice [http://www.chadinabhan.com]. He received his medical degree from Damascus University in Syria. After performing basic science research at Massachusetts General Hospital/Harvard Medical School, he completed his internal medicine residency as well as an MBA in Healthcare Management at Loyola University in Chicago. Dr. Nabhan maintains active medical licenses in five states, and has over 300 peer-reviewed articles and abstracts. He is also a sought-after speaker, moderator, facilitator, and the creator and host of his own podcast, "Healthcare Unfiltered" [https://www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA]. Jessica Aldridge, Co-Host and Producer of EcoJustice Radio, is an environmental educator, community organizer, and 15-year waste industry leader. She is a co-founder of SoCal 350, organizer for ReusableLA, and founded Adventures in Waste. She is a former professor of Recycling and Resource Management at Santa Monica College, and an award recipient of the international 2021 Women in Sustainability Leadership and the 2016 inaugural Waste360, 40 Under 40. More Info/Resources: Buy the book, Toxic Exposure: https://chadinabhan.com/mybooks/ Salon Article: https://www.salon.com/2023/02/25/glyphosate-roundup-chadi-nabhan-interview/

Dr. Patel, of the Swedish Cancer Institute in Seattle, Washington, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss novel frontline therapies in the lymphoma space, including the bispecific antibody glofitamab. They also discuss bispecifics versus chimeric antigen receptor (CAR) T-cell therapy, fixed duration therapy and step-up dosing, and how to sequence therapy.

In this episode of "The HemOnc Pulse," Dr. Goodman, an Associate Professor of Medicine at the University of California San Diego, joins Chadi Nabhan, MD, MBA, FACP, to discuss Castleman Disease. Dr. Goodman explains why the rare disease is often mismanaged, how each subtype is diagnosed and treated, and how it's comparable to hematologic cancers like lymphoma or myeloma.

Elias Jabbour, MD, an Executive Editor of Blood Cancers Today and a Professor of Leukemia at the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss the function of measurable residual disease in treating acute lymphocytic leukemia (ALL) and other progress that has been made in treating patients with Philadelphia chromosome-positive and Philadelphia chromosome-negative ALL.  Dr. Jabbour also provides a brief historical perspective on tyrosine kinase inhibitors (TKIs), explaining how the therapies have improved survival outcomes in Ph+ ALL with or without transplantation. 

Join host Dr. Chadi Nabhan and special guest Dr. Rachna Schroff for a deep dive into the latest highlights from this year's ASCO-GI meeting. Explore novel oncology research, groundbreaking trials, and the transformative role molecular profiling and liquid biopsies are playing in revitalizing the field of gastrointestinal cancer. Don't miss these essential highlights from this year's meeting. For more information, please visit: www.CarisLifeSciences.com

Uncover the path to equitable clinical trials in the latest Caris Molecular Minute podcast with host Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance and his guest, Dr. Ishwaria Subbiah, Executive Director at Sarah Cannon Research Institute. Together, they explore ways to enhance patient access and enrollment, mitigate disparities, and foster equality in clinical trials. Don't miss this thought-provoking conversation aimed at reshaping the narrative for a more inclusive and impactful future in cancer care and research. For more information, please visit: www.CarisLifeSciences.com

This episode features a conversation between Dr. Shastri, an Assistant Professor of Medicine at the Montefiore Einstein Comprehensive Cancer Center in the Bronx, New York, and The HemOnc Pulse host, Chadi Nabhan; MD; MBA; FACP; on the latest news in myelodysplastic syndromes (MDS), including the final readout from the COMMANDS trial and the clinical implications of TP53-mutated MDS.

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. Ari VanderWalde, Global Head of Clinical Trials at Caris Life Sciences. Join them as they delve into the world of clinical trials, exploring the intricacies of clinical research, providing valuable insights into Caris' contributions, and the accessibility of these transformative opportunities. For more information, please visit: www.CarisLifeSciences.com

Saad Usmani, MD, MBA, FACP, Chief of the Myeloma Service at the Memorial Sloan Kettering Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, on The HemOnc Pulse to chat about the latest research in multiple myeloma from the 65th American Society of Hematology (ASH) Annual Meeting and Exposition. Dr. Usmani shares insights on the evolution in myeloma treatment since he first started practicing in the hematologic oncology space. He also reflects on the Perseus and IsKia trials, which were presented at ASH 2023.

In this episode of The HemOnc Pulse, Jerald Radich, MD, of the Fred Hutchinson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss various abstracts on acute myeloid leukemia (AML) presented at the 2023 American Society of Hematology (ASH) Annual Meeting & Exposition. The conversation centered around menin inhibitors for the treatment of AML, the effect of measurable residual disease-positivity on transplantation outcomes, and whether age plays a role in transplantation.

Join Dr. Chadi Nabhan, Chairman of the Caris Precision Oncology Alliance, in a captivating podcast conversation with special guest Dr. Emil Lou, Associate Professor of Medicine at the University of Minnesota. Delve into the intricate connections between pathogens and cancer, exploring both research breakthroughs and the clinical implications. Gain valuable insights into the current landscape and discover what the future holds for this dynamic intersection of science and medicine. For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down for an engaging podcast interview with Dr. David Braxton, Chief of Service for Molecular Pathology at Hoag Hospital in Newport Beach, California. Explore Dr. Braxton's remarkable career as a molecular pathologist and delve into the pivotal role molecular pathologists play in precision oncology, while examining the progressive integration of artificial intelligence within molecular pathology. For more information, please visit: www.CarisLifeSciences.com

Dr. Cortes, who serves as Director of the Georgia Cancer Center at Augusta University, joins host Chadi Nabhan, MD, MBA, FACP, to chat about the “boom” in treatments for chronic myeloid leukemia (CML), and where he sees a need for balance. Dr. Cortes discussed the evolution of tyrosine kinase inhibitors (TKIs) and the multiple generations of TKIs that are now available. Second-generation TKIs can lead to earlier and deeper responses than first-generation TKIs, he said, noting that this means patients receiving second-generation TKIs are more likely to be able to discontinue treatment. “If I was diagnosed with CML, I would take a second-generation TKI,” Dr. Cortes said. However, Dr. Cortes emphasized that the first-generation TKI imatinib comes with a lower risk of serious side effects than second-generation TKIs. This is an important consideration because “most people are going to do well and have a normal life expectancy” on imatinib, he said. It is critical to evaluate multiple factors when choosing between a first-generation TKI and a second-generation TKI. This means involving patients in the decisions about treatment to ensure they are comfortable with the balance of efficacy and safety, he said. “I certainly would rather have more bags under my eyes than a heart attack,” Dr. Cortes said. “So, we need to balance that, and I think that sometimes we've been a little too obsessed on [obtaining] the lowest possible [polymerase chain reaction] value, and we lose the context of other elements that are important, such as risks, and comorbidities and side effects.” He also discussed a population of patients who remain challenging to treat despite the evolution of therapies for CML. “The most difficult patient is one without a mutation,” Dr. Cortes said, noting this is because response rates are lowest for those without a mutation and “you don't know why they are not responding.”

Join Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, and Dr. Salma Jabbour, Clinical Chief, Radiation Oncology and Vice Chair of Clinical Research & Faculty Development at RWJUH/Rutgers Cancer Institute, as they delve into the depths of radiation therapy in cancer care. Together they'll unravel the intricacies of this vital treatment option, covering its mechanisms, innovations, and the pivotal role it plays in the journey towards effective oncological treatment for patients. For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Jeanine Cervoni, Senior Director, Commercial Education at Caris Life Sciences in this latest episode of the Caris Molecular Minute podcast series. Join them in this empowering podcast as she shares the strength, resilience and hope that powered her through her personal breast cancer journey. For more information, please visit: www.CarisLifeSciences.com

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. George Sledge, Executive Vice President and Chief Medical Officer at Caris Life Sciences. Together they delve into his inspiring career as a prominent breast cancer specialist, his passion for this field, and his vision for the future of breast cancer care. For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

Caris Precision Oncology Alliance Chairman, Dr. Chadi Nabhan, sits down with Dr. Tina Bhatnagar, Associate Professor, Director of Hematology and Medical Oncology at West Virginia University. Together they discuss disparities research, the types of methodologies used and what can be done to mitigate the disparities seen in practice. For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

On this episode of The HemOnc Pulse, guest Jonathan Friedberg, MD, MMSc, a hematologic oncologist at the University of Rochester Medicine – Wilmot Cancer Institute, chats with host Dr. Chadi Nabhan on the subtle but important shift in the treatment landscape of diffuse large B-cell lymphoma (DLBCL)in the post-POLARIX trial era. The POLARIX trial, which was designed to improve upon the standard R-CHOP regimen for DLBCL treatment, investigated the potential of polatuzumab vedotin. The phase III trial ultimately resulted in the US Food and Drug Administration approving the treatment in previously untreated DLBCL, not otherwise specified, or high-grade B-cell lymphoma. The approval is for patients with an International Prognostic Index (IPI) score of two or greater. "I think that this was a robustly done randomized placebo-controlled trial that showed a small but clinically significant benefit as far as progression-free survival in patients with IPI score of two and above [in] large B cell lymphoma," he said.

Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, live at the Eleventh Annual Meeting of the Society of Hematologic Oncology to discuss the phase III COMMANDS trial, the recent approval of luspatercept, and other developments in myelodysplastic syndromes (MDS) treatment and research. Dr. Garcia-Manero spoke about the design of the phase III COMMANDS trial, which evaluated luspatercept versus epoetin alfa for the treatment of anemia in patients with lower-risk MDS who required red blood cell (RBC) transfusions but had not previously received an erythropoiesis-stimulating agent. “The study is very interesting in that it's very well controlled … and the data [are] very clear,” he said. The phase III trial showed 58.5% of patients receiving luspatercept achieved the primary endpoint of RBC transfusion independence for at least 12 weeks with a mean hemoglobin increase of at least 1.5 g/dL within the first 24 weeks, while this was only reported in 31.2% of patients receiving epoetin alfa.

Dr Chadi Nabhan, MD, is an oncologist who has been involved in litigation cases with Monsanto. In this video, we explore glyphosate and his involvement in the Monsato Trials. Remember to Like, Share, and Subscribe for more insightful discussions!   Topics Discussed:   Who is Dr Chadi Nabhan? Chadi's clinical experience in Oncology  Chadi's most memorable Oncology patient story  What is Cancer and what causes it?  Treatment options and Preventative Measures?   Cancers of the Gut Introduction to Monsanto Trial - Round Up- Glyphosate Martha's top gut health tip History of Glyphosate and Round up GMO Round up ready seeds  When did large scale Glyphosate exposure start?  Cancer, Chronic Disease and Glyphosate  How to mitigate the risks of Glyphosate?  EPA and Glyphosate How to reduce Glyphosate exposure  Why did Chadi testify against Monsanto?  Toxic Exposure Book Monsanto Trial Timeline  Monsanto Estimated Payout  Health is Wealth  Flow on effects of Glyphosates  Just say no to Glyphosate  Chadi's gut health message   Sponsor: Nourishme Organics https://www.nourishmeorganics.com.au/ 10% off using code : happygut   Connect with Kriben Govender here:  https://linktr.ee/kribengovender   Connect with Chadi Nabhan: https://chadinabhan.com/   Download links               If you enjoyed this episode and would like to show your support:   1) Please subscribe on Apple Podcasts, give us 5 stars and leave a positive review     Instructions:   - Click this link  https://itunes.apple.com/au/podcast/gut-health-gurus-podcast/id1433882512?mt=2   - Click "View in Itunes" button on the left-hand side - This will open the Itunes app - Click the "Subscribe" button - Click on "Ratings and Reviews" tab - Click on "Write a Review" button   Non-Itunes users can leave a Google Review here: https://goo.gl/9aNP0V     2) Subscribe, like and leave a positive comment on Youtube   https://www.youtube.com/channel/UCq5KxLvGIY4r6SqNaAphEUw?sub_confirmation=1   3) Share your favourite episode on Facebook, Instagram, and Stories 4) Let your friends and family know about this Podcast by email, text, messenger etc   Thank you so much for your support. It means the world to us.  

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed will include current treatment options, how treatment decision are made, and when treatment should be given. For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

Dr. Chadi Nabhan is an oncologist who testified as an expert witness in the first three litigation trials against Monsanto and their potentially cancer-causing herbicide Roundup.   He chats with Dr. Anthony Gustin about all the “courtroom drama” and research he uncovered.   Roundup is the most common weed killer in the world. Glyphosate (the active ingredient) taints our soil, waterways, and food — it's even in 97% of people's urine.   Dr. Nabhan specializes in Non-Hodgkin's Lymphoma, a disease in which malignant cancer cells form in the lymph system. He explains Roundup's link to cancer and other health conditions and why the courts have been ruling plaintiffs billions of dollars in damages.   You'll also hear about: The chemical history of glyphosate Why Roundup's formulation increases glyphosate absorption in our skin How researchers in the Agricultural Health Study (AHS) and regulators like the EPA mishandled the science linking glyphosate to cancer Why the internal “Monsanto Papers” reveal the company knew about these dangers all along What Roundup-ready seeds (i.e., glyphosate-resistant plants) mean for the health of our food system Dr. Nabhan's new book: Toxic Exposure: The True Story Behind The Monsanto Trials And The Search For Justice   Resources mentioned in this episode: Dr. Chadi Nabhan's website Dr. Nabhan's Twitter Dr. Nabhan's book: Toxic Exposure: The True Story Behind The Monsanto Trials And The Search For Justice

In this episode Courtenay invites to the show medical oncologist, author, and award-winning podcast host, Dr. Chadi Nabhan. Dr. Chadi was an expert witness in the first three litigation trials against Monsanto and the product Roundup. In his latest book, Toxic Exposure, he chronicles the story through his perspective backed with the unfiltered facts. This conversation is filled with invaluable information about existing toxins, the lack of informed consent to their consumption, and how to combat their harmful effects. Connect with Dr. Chadi: Website: https://chadinabhan.com/  Podcast: Healthcare Unfiltered Book: Toxic Exposure: The True Story Behind The Monsanto Trials And The Search For Justice  ————————————————— Disclaimer: this is intended to be inspiration & entertainment. We aim to inform, inspire & empower. Guest opinions/ statements are not a reflection of the host or podcast. Please note these are conversational dialogues. All statements and opinions are not necessarily meant to be taken as fact. Please do your own research. Thanks for watching! ————————————————— Follow & Connect with Courtenay: https://www.courtenayturner.com Twitter: https://twitter.com/KineticCourtz TruthSocial: https://truthsocial.com/@CourtenayTurner Instagram: https://instagram.com/kineticcourtz?utm_medium=copy_link Telegram: https://t.me/courtenayturnerpodcastcommunity Read some of her articles: https://www.truthmatters.biz Listen to &/or watch the podcast here! https://linktr.ee/courtenayturner Support my work & Affiliate links: https://www.buymeacoffee.com/courtzt https://zstacklife.com/?ref=COURTENAYTURNER FOX N SONS Coffee: https://www.foxnsons.com Promo Code: CTP The wellness company: https://www.twc.health/?ref=UY6YiLPqkwZzUX Enroll link: https://app.sharehealthcare.com/enroll? Referral code: courtz Www.HolyHydrogen.com Discount code: UPRISING144K LMNT: http://drinklmnt.com/CourtenayTurner Ignite Sales: https://www.universityofreason.com/a/29887/KVR3yvZo Mindset workshop: https://www.universityofreason.com/a/2147526145/KVR3yvZo Critical thinking trivium method: https://www.universityofreason.com/a/2147486641/KVR3yvZo Solutions webinar: https://www.universityofreason.com/a/2147492490/KVR3yvZo Richard's GTW freedom vault: https://www.universityofreason.com/a/2147506649/KVR3yvZo https://www.universityofreason.com/a/29887/KVR3yvZo ©2023 All Rights Reserved  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we sat down the Dr. Chadi Nabhan to discuss the first three trials against Monsanto, all of which found Monsanto guilty of their link to the plaintiff's cancer. Dr. Chadi Nabhan is an award-winning hematologist and oncologist who served as an expert witness in the court cases against Monsanto, the manufacturer of Roundup and other herbicides.  Tune in to hear the shocking details of the court cases linking glyphosate-based herbicides to cancer. Find Dr. Chadi NabhanBook // Toxic Exposure:  The True Story Behind the Monsanto Trials and the Search for JusticeWebsite // https://chadinabhan.com/Podcast // Healthcare UnfilteredFind HomegrownInstagram // @homegrown_education, @lizhaselmayer, @joeyhaselmayerWebsite // homegrowneducation.orgNatural Home Goods // Haselmayer Goods

Though the International Agency for Research on Cancer concluded that glyphosate, the main ingredient in Roundup, is a probable carcinogen, it remains the most widely used herbicide in the United States. My guest this week, Dr. Chadi Nabhan is here to tell the story behind three court cases that concluded with Roundup maker Monsanto owing large sums to glyphosate users who developed non-Hodgkin lymphoma. Podcast Links for Show notes Download my free eBook 5 Steps to Your Best Garden Ever - the 5 most important steps anyone can do to have a thriving garden or landscape. It's what I still do today, without exception to get incredible results, even in the most challenging conditions. Subscribe to the joegardener® email list to receive weekly updates about new podcast episodes, seasonal gardening tips, and online gardening course announcements. Check out The joegardener® Online Gardening Academy for our growing library of organic gardening courses. Follow joegardener® on Instagram, Facebook, Pinterest, and Twitter, and subscribe to The joegardenerTV YouTube channel.

Dr. Chadi Nabhan one of the lead doctors who testified during the Monsanto Roundup trials, and proved that glyphosate containing Roundup Ready weed killer does in fact cause non-Hodgkin's lymphoma, joins the show to talk about the trials and this alarming chemical. Dr. Nabhan gives us a first hand account of what it was like to testify in the trial, and some of the surprising things that happened during his time in court. He also goes over what non-Hodgkin's lymphoma is, and the many other health issues Roundup may be contributing to. We also go over the political aspects of Roundup and glyphosate, what the EPA is actually doing about it, and the future of this dangerous chemical. So many important topics covered on this pervasive and sometimes lethal chemical, so make sure to tune in!  On today's podcast, you will learn: How Dr. Nabhan got involved in the Monsanto trials. Fascinating stories about the courtroom and how the trials unfolded. Is glyphosate causing other severe health issues? How Monsanto used employees to ghostwrite medical articles to counter the true findings by IARC. What is non-Hodgkin's lymphoma and the type Mr. Johnson had in the major Dewayne Johnson v. Monsanto Company trials. The fascinating story that lead Dr. Nabhan to write his incredible book Toxic Exposure. What do to if you believe you've had dangerous exposures to glyphosate. The politics of involved around Monsanto and the future of glyphosate.   Dr. Chadi Nabhan's Bio: Chadi Nabhan, MD, MBA, is an award-winning hematologist and a medical oncologist who previously hosted an award-winning podcast, Outspoken Oncology, which has now been rebranded to Healthcare Unfiltered – an honest, raw, timely podcast tackling any and all topics in healthcare. No edits and no filters; that is “Healthcare Unfiltered.”  Combining his background in clinical care, cancer research, precision medicine, genomics, clinical trials, real-world data, controversies in medicine, and health care advocacy, Dr. Nabhan brings a unique and powerful perspective to current medical events. It's the weekly podcast that you don't want to miss. You can learn more about Dr. Nabhan and his work at www.chadinabhan.com Make sure to pick up his incredible book Toxic Exposure! https://chadinabhan.com/mybooks/   ✨SUBSCRIBE✨ http://bit.ly/38pyo1U  

Here on the podcast, we've talked about the effect of glyphosate (aka Round-Up) on the soil, but what about humans? Dr. Chadi Nabhan, who is board-certified in internal medicine, hematology, and medical oncology, has first hand experience in this field as he was called in to be an expert witness in Monsanto trials in 2018 and 2019. Buckle up! This is a behind-the-scenes look like none other.Learn more about my NEW book Old-Fashioned on Purpose (and how to get pre-order bonuses): http://oldfashionedbook.com/Learn more about Dr. Chadi Nabhan here: https://chadinabhan.com/Find Dr. Nabhan's book Toxic Exposure here: https://chadinabhan.com/mybooks/Follow Dr. Nabhan on twitter here: https://twitter.com/chadinabhanHave a message you want to share with the world? Apply to be a guest on the Old-Fashioned on Purpose podcast here: https://www.theprairiehomestead.com/podcast-guest-applicationWeekly musings from my homestead: http://theprairiehomestead.com/letterMy essays on an old-fashioned life: www.prairiephilosophy.comMy homesteading tutorials & recipes: www.theprairiehomestead.comOur Wyoming-raised, grass-finished beef: http://genuinebeefco.comJill on Twitter: http://twitter.com/homesteaderJill on Instagram: @jill.wingerJill on Facebook: http://facebook.com/theprairiehomestead